Evaluation of serum fatty acid binding protein-4 (FABP-4) as a novel biomarker to predict biopsy outcomes in prostate biopsy naïve patients.

Ahmed M HarrazNora AtiaAmani IsmailAbdallah ShadyHashim FargHady GabrMohamed FoudaHassan Abol-EneinA F Abdel-Aziz

Published in: International urology and nephrology (2020)

FABP-4 is an independent predictor for both the diagnosis and high-grade Gleason score at PNB. This novel biomarker might have a promising role in optimizing PNB outcomes.

Keyphrases

binding protein
prostate cancer
high grade
end stage renal disease
fatty acid
ejection fraction
newly diagnosed
chronic kidney disease
ultrasound guided
peritoneal dialysis
type diabetes
adipose tissue
patient reported outcomes